NHS England has announced that men whose high-risk prostate cancer has not yet spread will be able to receive the drug, ...

Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...

Orion predicted strong growth for darolutamide, the prescription prostate-cancer medication it co-developed with Bayer.

Thousands of men with prostate cancer will be given a life-extending drug on the NHS, following a three-year battle to expand ...

Around 55,000 new cases of prostate cancer are diagnosed in the UK every year, and super drug abiraterone will offer hope to ...

Thousands of men with prostate cancer will be offered a life-extending drug on the NHS within weeks. For the first time patients whose prostate cancer has not spread will be able to receive the drug ...

Thousands more men with prostate cancer will be eligible for a life-extending drug on the NHS. The move means the drug, known ...

Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...

DelveInsight’s Metastatic Castration-Resistant Prostate Cancer pipeline report depicts a robust space with 75+ active players working to develop 75+ pipeline therapies for Metastatic ...